NEW YORK (GenomeWeb News) – DxTerity Diagnostics today said that the Scottsdale Clinical Research Institute in Arizona will use the firm’s Quenched Auto Ligating reagents for development of a microRNA-based cardiac test.
 
The test will measure the expression of a microRNA biomarker in heart biopsy tissue samples, which has been shown to correlate with post-operative heart arrhythmia. DxTerity said that SCRI will use its QUAL reagents to validate the biomarker’s ability to reveal at-risk patients before an arrhythmia strikes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.